1. Dalakas MC. Polymyositis, dermatomyositis, and inclusion-body myositis. N Engl J Med. 1991; 325:1487–98.
Article
2. Stertz G, Polymyositis. Berl Kin Wochenschr. 1916; 53:489.
3. Kim SM, Choi YH, Oh MD, Nam TS, Chung MH, Rai HJ, et al. A clinical analysis of 100 patients with dermatomyositis – polymyositis. Korean J Med. 1990; 39:812–23.
4. Lee SW, Jung SY, Park MC, Park YB, Lee SK. Malignancies in Korean patients with inflammatory myopathy. Yonsei Med J. 2006; 47:519–23.
Article
5. Barnes BE, Mawr B. Dermatomyositis and malignancy. A review of the literature. Ann Intern Med. 1976; 84:68–76.
6. Ponyi A, Constantin T, Garami M, Andras C, Tallai B, Vancsa A, et al. Cancer-associated myositis: clinical features and prognostic signs. Ann N Y Acad Sci. 2005; 1051:64–71.
Article
7. Briani C, Doria A, Sarzi-Puttini P, Dalakas MC. Update on idiopathic inflammatory myopathy. Autoimmunity. 2006; 39:161–70.
8. Racanelli V, Prete M, Minoia C, Favoino E, Perosa F. Rheumatic disorders as paraneoplastic syndromes. Autoimmun Rev. 2008; 7:352–8.
Article
9. Chen YJ, Wu CY, Shen JL. Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study. Br J Dermatol. 2001; 144:825–31.
Article
10. Wakata N, Kurihara T, Saito E, Kinoshita M. Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study. Int J Dermatol. 2002; 41:729–34.
Article
11. Carsons S. The association of malignancy with rheumatic and connective tissue disease. Semin Oncol. 1997; 24:360–72.
12. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, et al. Frequency of specific cancer types in dermatomyositis and polymyositis; a population based study. Lancet. 2001; 357:96–100.
13. Kojima M, Itoh H, Shimizu K, Saruki N, Murayama K, Higuchi K, et al. Malignant Lymphoma in Patients with Systemic Rheumatic Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis, and Dermatomyositis): A Clinicopathologic Study of 24 Japanese Cases. Int J Surg Pathol. 2006; 14:43–8.
Article
14. Chung L, Genovese MC, Fiorentino DF. A pilot Trial of Rituximab in the Treatment of Patients With Dermatomyositis. Arch Dermatol. 2007; 143:763–7.
Article